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Mechanisms of Oncogene Cooperation:
Activation and Inactivation of a Growth
Antagonist
by Michelle M. Ragozzino,*Alan Kuo,*James DeGregori,*
Nancy Kohl,*t and H. Earl Ruley*
Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes
to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the
ras or sis oncogenes requires the continuous expression of a second collaborating oncogene, such as
adenovirus-5 ElA or SV40 large T-antigen. Our studies suggest that the function of the nuclear collabo-
rators is to antagonize dominant growth controls which limit the ability of REF52 cells to proliferate in
response to mitogenic stimuli.
Introduction
Oncogenes are genes implicated in carcinogenesis by
virtue of their associations with oncogenic viruses and
tumor-specific chromosome abnormalities and by their
ability to transform cultured cells to atumorigenic state
(1,2). Mutations and virus associations enable oncogenes
to facilitate autonomous cellgrowth eitherbyincreasing
the expression of activities that promote cell prolifer-
ation orbyinterfering with controls thatnormally serve
to restrict cell growth. As carcinogenesis is generally
believed to be a multistep process, malignant pheno-
types may frequently require multiple alterations af-
fecting several levels ofgrowth control (3). This is sup-
ported by gene-transfer experiments in which two or
more oncogenes are required to transform normal cells
to a malignant state (4-6).
Collaborations between oncogenes indicate that reg-
ulatory mechanisms that preclude transformation by
one oncogene can be circumvented by a second onco-
gene. This implies that certain oncogenes actively in-
fluence the way that cells respond to other oncogenes.
Gene transfer experiments indicate that expression of
an activated ras oncogene is sufficient totransforn cells
from avariety ofestablished celllines (7-9). Incontrast,
*Center for Cancer Research and Department of Biology, Massa-
chusetts Institute of Technology, 77 Massachusetts Avenue, Cam-
bridge, MA 02139.
tPresent address: Merck, Sharp, and Dohme Research Labs, West
Point, PA 19486.
Address reprint requests to H.E. Ruley, Center for Cancer Re-
search and Department ofBiology, Massachusetts Institute of Tech-
nology, 77 Massachusetts Avenue, Cambridge, MA 02139.
primary and early passage rodent cells are transformed
by ras oncogenes only at very low frequencies unless
cotransfected with collaborating genes such as ElA or
myc (9,10).
Several observations suggested that in vitro estab-
lishment is a necessary prerequisite to transformation
by ras oncogenes. First, the susceptibility of normal
hamster cells to transformation by ras coincides with
in vitro establishment (9). Second, genes such as ElA,
p53, SV40 large T-antigen, and myc, which collaborate
with ras to transform primary cells, also facilitate im-
mortalization (11-15). Finally, mutational analysis of
ElA revealed a tendency for mutations that affect in
vitro establishment functionstoalsoinfluencetheability
of ElA to collaborate with ras in the transformation of
primary cells (16,17). However, some ElA genes are
defective in immortalization but are nevertheless able
to collaborate with ras in transformation (17-19).
Though informative, the use ofprimary cellsintrans-
formation studies has several limitations. First, a va-
riety of factors including variations in cell type, levels
ofras expression, inhibitory effects ofnormal cells, and
other environmental factors can influence transforma-
tion by ras alone (20-24). Second, the fact that immor-
talization appears to be a necessary prerequisite for
oncogenic transformation in vitro may simply reflect
difficulties imposing a transformed phenotype over a
dominant commitment to senesce. Finally, problems
working with nonestablished cell clones complicate any
assessment ofthe phenotypic effects ofras alone. As a
result, the mechanisms responsible for oncogene coop-
erationinnonestablished cellshavebeendifficulttoana-
lyze.RAGOZZINO ET AL.
We have examined oncogene interactions using an
established line of Fisher rat embryo fibroblasts,
REF52, which, unlike most established lines, is not sta-
bly transformed by activated ras oncogenes. Instead,
transformation of REF52 cells by ras strictly requires
the presence ofa collaborator, such as adenovirus ElA
or SV40 large T-antigen (25). The transformation prop-
erties of the REF52 line indicate that the role of the
viral oncoproteins extends beyond that of promoting
establishment and suggests that while immortality may
be a necessary prerequisite for transformation by ras,
it is not sufficient. While other established cell lines
resist transformation by ras (14,26), the REF52 line
provides the clearest evidence that oncogenes can com-
plement in a genetic sense to elicit a malignant phen-
otype.
Multistep Transformation of REF52
Cells
In earlier studies, REF52 cells were transfected with
T24-Ha-ras linked to the neomycin-resistance gene and
clones were selected in G418. The vast majority ofthe
resistant clones were morphologically indistinguishable
from the parental line, unable to grow in soft agar, not
tumorigenic in nude mice, and expressed low levels of
p21T24Ha-ras (30% ofthelevelofendogenous Ha-rasp21).
While 1 in 1000cloneswasmorphologicallytransformed,
these rare ras-only transformants experienced mor-
phological crisis and ceased growing. p21T24Ha-ras levels
in these abortive transformants were extremely high
(greater than 100-fold higher than the endogenous Ha-
rasp21), indicatingthat evenhighlevelsoftheactivated
ras oncoprotein are not sufficient toinduce stable trans-
formation in the absence of a collaborating oncogene
(25).
In contrast, cells transfected with T24Ha-ras/neo and
either adenovirus E1A or SV40 large T-antigen, gave
rise totransformed neo-resistant colonies (25,27). While
p21T24Ha-r,S levels in these transformed clones varied
considerably, ranging from levels 2- to 10-fold greater
than the endogenous p21l-Ha-ra8 all ofthe transformed
clones tested formed colonies in soft agar and induced
rapidly lethal tumors in nude mice. These studies in-
dicate that relatively low levels of the oncogenic p21
are sufficient to transform in the presence of a collab-
orator and that the collaborating oncogene supplies ac-
tivities that are not duplicated by increased ras expres-
sion.
Conditional transformation of REF52 cells has also
been achieved by cotransfecting a temperature-sensi-
tive allele ofSV40 large T-antigen (tsA58) and T24 Ha-
ras (27). Thus, two-thirds ofthe clonestransfected with
T24 Ha-ras and tsA ceased growing, arresting predom-
inantly in G2 or late S-phase, when transformed from a
permissive to a nonpermissive temperature for T-an-
tigen expression. p21i24Ha-ras levels were unaffected by
the temperature shift. This study indicates that trans-
formation by ras requires continuous expression of a
collaborating oncogene, and suggests that E1A and
SV40 large T-antigen may enable ras to transform
REF52 cells by circumventing cellular responses to ras
which inhibit cell proliferation.
Oncogenic p21 Induces Quiescent
REF52 Cells to Proliferate
To investigate early phenotypic effects of ras, acti-
vated and normal forms of p21 were introduced into
serum-arrested REF52 cells using the bead-loading
method (28). The method utilizes small (75-500 ,um)
glass beads to mechanically disrupt the plasma mem-
brane to an extent that allows proteins to enter cells
without significantly affecting cell viability. p21Ha,-s
proteins were purified from insect cells infected with
baculovirus vectors expressing high levels of posttran-
slationally modified T24 and c-Ha-ras p2ls. As shown
in Figure 1, upto31% ofthe cells loaded inthepresence
ofa 2.2 mg/mL solution ofthe activated p21 were stim-
ulated to enter S phase within 24 hr, whereas cells
loaded with bovine serum albumin failed to respond.
Introduction of nonactivated c-Ha-ras p21 was less ef-
fective in stimulating cell cycle progression than acti-
vated p21 (data not shown). Maximum incorporation of
3H-thymidine was observed 12 to 24 hr after exposure
to bead loaded p21T24Ha-ras. At concentrations greater
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FIGURE 1. Bead-loaded T24ras p21 stimulates serum-arrested
REF52 cells to progress through the cell cycle. REF52 cells,
seeded on glass coverslips, were transferred to Dulbecco's modi-
fied Eagle's media containing 1% ITS+ (insulin, transferrin se-
lenium, and oleic acid/bovine serum albumin complex). After 48
hr, growth-arrested REF52 cells were washed with phosphate-
buffered saline (PBS), coveredwith50 ,LPBScontainingvarying
amounts ofT24ras p21, orbovine serum albumin (BSA), andwere
bead-loaded using 75- to 150-Rm beads, as described (28). BSA
loaded at 3.6 mg/mL resulted in 0.1% labeled nuclei. Cells were
labeledwith2.5 ,uCi/mL 3H-thymidinefor24hrpost-bead-loading
and then fixed and processed for emulsion autoradiography.
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than 1 mg/mL, p21r24Ha-ras also induced morphological
transformation as well as stimulating DNA replication.
Similar results have been reported using microin-
jected p21 (29); thus, although resistant to transfor-
mation, REF52 cells are mitogenically stimulated by
introduction ofp21T24Ha-ras. In this regard, REF52 cells
respond to oncogenic p21 in a manner not unlike cells
that are susceptible to transformation (29,30). As ras
is thought to transduce signals from growth factor re-
ceptors, controls that prevent ras from transforming
REF52 cells would appear to act at a level subsequent
to or independent of a mitogenic response to ras.
ElA Enables the sis Oncogene to
Transform REF52 Cells
Similar growth controls may also regulate transfor-
mation of REF52 by c-sis, the B chain of the platelet-
derived growth factor (PDGF) (31,32). Transformation
by sis is thought to result from autocrine stimulation
resulting from binding to the growth factor to PDGF
receptors.
Quiescent REF52 cells were stimulated to enter S
phase by recombinant p28c"s, indicatingthat these cells
have receptors for PDGF (Fig. 2). In addition, p28'-ss
induced, with expected kinetics, the transcription of
several growth factor-induced early response genes
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FIGURE 2. T24 Ha-ras p21 inhibits cellular responses to mitogenic
stimuli. REF52 cells expressing neo (N6) or T24 Ha-ras genes
(RN14) were seeded on cover slips at a density of 400 cells/cm2
and grown for 48 hr. At this time, monolayers were washed twice
with phosphate-buffered saline and transferred to Dulbecco's mod-
ified Eagle's medium ITS+ (insulin, transferrin selenium, and
oleic acid/bovine serum albumin complex). After 48 hr, the indi-
cated growth factors were added to the GO-arrested cells. Samples
were labeled for 12 hr at 12-hr intervals with 5 Ci/mL 3H-
thymidine and then processed for emulsion autoradiography. Re-
sults for the time period 12 to 24 hr after growth factor addition
(i.e., the interval with maximum response) are plotted. The
growth factor concentrations were as follows: serum (10% fetal
calf); recombinant platelet-derived growth factor B-chain (PDGF,
40 ng/mL); epidermal growth factor (EGF 100 ng/mL). RN14 cells
also failed to respond to phorbol 12-myristate 13-acetate (TPA) at
10 ng/mL (data not shown).
(i.e., igc,fos, andJE), suggestingthatthesignaltrans-
duction pathway from the cell surface to the nucleus is
intact (data not shown). However, when REF52 cells
are cotransfected with c-sis and the gene for neomycin
resistance, all of the resistant colonies were indistin-
guishable from REF52 cells transfected with the neo-
mycin-resistance gene alone. In each case, similar num-
bers ofneo-resistant colonies were obtained, suggesting
that the sis gene was not toxic to REF52 cells. E1A
introduced together (Table 1) or in a secondary trans-
fection (data not shown), enabled c-sis to transform
REF52 cells to anchorage independence.
These results suggest that the ability of cells to be
mitogenically stimulated by sis growth factor, while
perhaps necessary, was not sufficient for stable trans-
formation. As with ras, ElA appears to circumvent
controls that prevents sustained exposure to a mito-
genic stimulus from transforming.
Collaborating Oncogenes Have
Complementary Effects on Cellular
Responses to Growth Factors
Since oncogenic transformation of REF52 cells can
require the activities oftwo oncogenes actingin concert,
these cells provide an opportunity to studythe biological
effects of individual oncogenes in the absence of sec-
ondary phenotypic changes resulting from transfor-
mation. REF52 cells expressing low levels of activated
Ha-ras p21 (T24REF) are morphologically normal and
fail to form either colonies in soft agar or tumors in nude
mice. However, these cells express functional ras on-
coproteins, since ElA and SV40 large T-antigen each
efficiently transform when transfected subsequently
(clone N6) (25).
When transferred to serum-free media, T24REF
(clone RN14) cells cease growing with kinetics indistin-
guishable from the neo-resistant REF52 control (clone
N6) (Fig. 3). Nevertheless, a marked difference was
evident between the cell lines upon restimulation by
individual mitogens. As shown in Figure 2, the presence
of even low levels of activated p21 interfered with the
ability of REF52 cells to progress into S phase upon
stimulation by phorbol 12-myristate 13-acetate, epider-
mal growth factor, PDGF or PDGF and epidermal
growth factor together. The response to serum, how-
ever, was unaffected or even moderately enhanced by
T24Ha-ras.
Cell lines individually expressing either ElA or SV40
large T antigen, although morphologically altered, were
not transformed, as assessed by their failure to grow
in soft agar or from tumors in nude mice. However, as
shown in Figure 2, the presence of either SV40 large
T antigen or ElA in REF52 cells allows for extended
proliferation in the absence of serum growth factors.
Thus, there is an apparent functional complementation:
ras inhibits proliferative responses tomitogenic stimuli,
while ElA and large T each enable REF52 cells to pro-
liferate in the absence of mitogenic stimuli. In other
words, REF52 cells appear to possess growth controls
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Table 1. Sis and adenovirus-5 EIA cooperate to transform REF52 cells.
Experiment Soft agar plating
Plasmid Transfected genes no. Selection efficiency
Homer6 neo 1 G418 < 0.005
2 G418 < 0.005
pSMRlMoNeo sis, neo 1 G418 < 0.005
2 G418 < 0.005
plAhgm Ad5 ElA, hph 1 Hygromycin < 0.005
2 Hygromycin < 0.005
pSMRlMoNeo 1 G418 0.6
+ plA Ad5 ElA, hph, sis 2 G418 0.2
3 G418 0.2
4 G418 0.1
pSMRlMoNeo Ad5 ElA, neo, sis, hph 1 G418 and 5.0
+ plAhmg 2 hygromycin 0.2
aREF52 cells, 2 x 105, were transfected with the indicated plasmids containing the following genes: Homer6, a neomycin (G418) resistance gene
(20), pSMRlMoNeo, a derivative ofpSMl (42), c-sis and neo genes expressed from the SV40 early promoter and moloney murine leukemia virus
LTR, respectively; plA, advenovirus-5 ElA (25); and plAhgm, Ad5 ElA and hygromycin resistance gene. Following selection with 0.4 mg/mL
G418 (Gibco, 50% active) and/or 0.1 mg/mL hygromycin B (Calbiochem), cells from at least 100 colonies were trypsinized, pooled, and plated in
media containing 0.37% agarose. Fresh agar-containing media was added to soft agar cultures once aweek for 3 to 4 weeks and then the cultures
were stained with p-iodonitrotetrazolium violet (Sigma). Soft agar plating efficiency refers to percent ofcells forming colonies 70 jLm in diameter
or larger.
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FIGURE 3. REF52 cells expressing adenovirus ElA or SV40 large
T-antigen continue to proliferate in serum-free media. Cell lines
were seeded at a density of3000 cells per 35 mm well and allowed
to attach and proliferate for 48 hr. Cells were then washed twice
with phosphate-buffered saline and transferred to media contain-
ing Dulbecco's modified Eagle's medium (DME) and 1% ITS +
(insulin, transferrin selenium, and oleic acid/bovine serumalbumin
complex). This is the zero time point. Cells were labeled for 12 hr
prior to each ofthe indicated time intervals in 1 mL ofDME/ITS +
containing 5 ,u Ci 3H-thymidine. Trichloroacetic acid-precipitable
counts were determined and expressed as a percent of the time
zero (i.e., label added from - 12 to 0hr) cpm. Results with REF52
clones expressing the following genes are plotted: neo, N6; T24
Ha-ras, RN14; adenovirus-5 ElA, Al; and SV40 large T-antigen,
WS1.
which limit the ability of the cells to proliferate in re-
sponse to mitogenic stimuli. These controls are acti-
vated by ras and are circumvented by ElA and SV40
large T-antigen.
A Dominant Antagonist Regulates
Transformation by ras and ElA
A series of cell fusion experiments were performed
to determine whether the growth controls that prevent
ras from transforming REF52 cells are dominant or
recessive. In principle, REF52 could differ from other
established rodent lines, which are transformed by ras
alone, in one oftwo ways: a) REF52 cells lack activities
that are required for transformnation by ras, and ElA
supplies the missing cellular functions; b) REF52 cells
possess an antagonist that prevents ras from trans-
forming, and ElA inactivates of circumvents the an-
tagonist. In orderto distinguish betweenthesetwo pos-
sibilities, cell lines, shown in Table 2, containing either
hygromycin or neomycin resistance markers, were
fusedusingpolyethylene glycolandselectedinthe pres-
ence of both antibiotics (33). Hybrid colonies were
pooled and plated in soft agar to assess whether any
expressed transformed phenotypes (Table 3).
When NRK cellstransformed byras were fused with
REF52 cells, 20-fold fewer colonies were obtained than
when normal NRK cells were fused with REF52. Fur-
thermore, the hybrid colonies obtained were morphol-
ogically nonnal and failed to produce any soft agar col-
onies, indicating that transformation of NRK cells by
ras was suppressed by fusion with REF52 cells. In con-
trast, the fusion of ras-transformed NRK cells with
ElA-expressing REF52 cells yielded transformed col-
onies, which formed colonies in soft agar with a fre-
quency of4%. Similar results were obtained with Rat2
cells were substituted for NRK cells (Table 3). Thus,
the growth controls that prevent ras fromtransforming
and act to inhibit proliferation in the presence of ras
are dominant, trans-acting, and are either circum-
vented or negated by function(s) of ElA.
Further evidence that REF52 cells possess a domi-
nant antagonist of transformation has come from the
analysis of spontaneous transformants induced by ac-
tivated ras oncogenes. We pooled 102 to 104 to neo-
mycin-resistant colonies isolated after transfecting
REF52 cells with T24Ha-ras, and 5 x 106 cells were
injected into nude mice. Tumors arose within 4 to 6
weeks, and the cell lines derived from each tumor were
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Table 2. Cell lines used as fusion partners.a
Soft agar
Transfected plating
Cell line Plasmid gene(s) Selection Morphology efficiency
REF52.H1 pY3 hph hygR Normal < 0.01
REF52.ElaHl plAhgm ElA, hph hyge Normal < 0.01
Rat2.H1 pY3 hph hyge Normal < 0.01
Rat2.G1 Homer6 neo neoR Normal < 0.01
Rat2.T24G3 pT24neo ras, neo neoR Transformed 34
NRK49EH1 pY3 hph hyge Normal 0.2
NRK49ET24G3 pT24neo ras, neo neoR Transformed 10
N5 (REF52) pKOneo neo neoR Normal 0.02
RT1 pT24neo ras, neo neoR Transformed 1
RC6T1 HO6T1 ras, neo neoR Transformed 3
RC6T2 HO6T1 ras, neo neoR Transformed 0.6
15-264 HO6T1 ras, neo neoR Transformed 5
aREF52, Rat2, and NRK49Fcells were transfected with the indicated plasmids. Plasmids expressed thefollowinggenes: pT24neo, an activated
Ha-ras gene derived from T24 human bladder carcinoma cells (25); plAhgm, the adenovirus 5 ElA gene linked to hph, the gene of hygromycin
B phosphotransferase; Homer6, neo (20); pY3, hph (43); HO6T1, T24 H-ras inserted into Homer6 (20); and pSVrasC, a T24 ras cDNA replacing
the neo ofpKOneo.
Table 3. Resistance of REF52 cells to transformation by ras is
dominant over susceptibility to transformation.a
Hybrids Soft agar
105 cells plating
NeoR parent x HygR parent fused efficiency
NRK49F.T24G3 REF52.H1 11 ± 5 < 0.003
NRK49F.H1 211 + 14 4 ± 3
Rat2.H1 209 + 7 4 ± 4
REF52.ElaH1 28 + 15 2 ± 1
Rat2.T24G3 REF52.H1 28 ± 18 0.04 ± 0.05
NRK49F.H1 121.3 ± 0.9 1.6 ± 0.3
Rat2.H1 175 ± 11 9 ± 2
REF52.ElaH1 20 ± 5 17 ± 4
aCells were fused with polyethylene glycol as described (33). After
9 to 12 days ofselection in media containing 400 ,ug/mL G418 and 100
Rg/mL hygromycin B, hybrid colonies were counted, trypsinized, and
plated in 0.37% soft agarose. The soft agar plating efficiency refers
to the percent of cells forming viable colonies after 3 weeks.
NRK49F.T24G3 and Rat2.T24G1 are NRK49F and Rat2 cell lines
transformed by T24 Ha-ras, respectively. Means and SEs for at least
two experiments are presented.
re-established inculture and used infusionexperiments
(Table 4). Fusions between tumorcells and theparental
REF52 cells failed to produce transformed hybrids,
whereas fusions between tumor cells and NRK or Rat2
lines yielded transformed colonies which grew in soft
agar. In addition, fusions between some of the tumor
lines and REF52 cells expressing ElA produced trans-
formed hybrids, indicating that the antagonist was neu-
tralized by ElA. This series offusions suggest that the
ras-induced tumors arose as a result of the loss of an-
tagonist functions which normally prevent transfor-
mation and not from the activation ofcellular functions
analogous to ElA.
While the biochemical mechanisms are yet unknown,
this genetically defined antagonist resembles an anti-
oncogene, a gene whose functional loss leads to trans-
formation. This is provocative, since the ability ofElA
proteins to bind the retinoblastoma gene product,
p1Q5Rb, is tightly linked to ElA activities that enable
Table 4. Spontaneous transformation of REF52 cells by ras
typically results from recessive changes.a
NeoRparent x Hyg' parent
RT1 REF52.H1
NRK49F.H1
Rat2.Hl
REF52.ElaHl
RC6T1
15-264
RC6T2
REF52.H1
NRK49F.H1
Rat2.H1
REF52.ElaH1
REF52.H1
NRK49F.H1
Rat2.H1
REF52.ElaHl
REF52.H1
NRK49F.H1
Rat2.Hl
REF52.ElaHl
N5 (REF52) REF52.H1
NRK49F.H1
Rat2.Hl
REF52.ElaHl
Hybrids/105
cells fused
11
16
76
148
1
68
51
6
0.5
53
89
2
4
113
9
9
62
9
18
35
Soft agar
plating
efficiency
< 0.01
0.2
0.5
3
< 0.01
6
6
ND
< 0.01
7
3
0.02
0.03
1.0
0.01
0.04
0.005
ND
< 0.005
< 0.005
aras-Transformed REF52 tumor lines (RT1, RC6T1, RC6T2, and
15-264) werefused withtheindicatedhyge cells. Celllines and meth-
ods are described in Tables 1 and 2 and in text. Fusions between
REF52 cells and ras-transformed REF52 cells isolated by in vivo
selection failed toproduce transformed hybrids. ND, notdetermined.
ras to transform primary baby rat kidney cells (34-36).
This raises the possibility that p1O5Rb is a component
ofthe transformation antagonist of REF52 cells. If so,
one would expect to observe differences in the levels of
plO5Rb in normal REF52 cells, and ras-transformed
REF52 tumor cells. However, the eight ras-induced
tumor lines examined thus far maintain a normal num-
ber ofintact Rb genes as well as unaltered levels ofRb
message. These results do not exclude the possibility
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of point-mutations or posttranslational alterations that
adversely affect the activity of p105Rb.
Summary
In summary, REF52 cells possess growth controls
that prevent a sustained mitogenic stimulus from trans-
forming. These growth controls are dominant and can
act in trans to antagonize transformation of rat cells
previously transformed by ras. Given that ras and sis
initially provoke REF52 cells to proliferate, the antag-
onist may itself be activated by mitogens as a part ofa
feed-back mechanism which limits cell proliferation.
ElA and SV40 large T are able to circumvent or inac-
tivate the antagonist. The extent to which this relates
tothemechanismbywhichthe viraloncoproteins enable
REF52cellstogrowintheabsence ofserumiscurrently
under investigation.
Future studies will focus on genes, such as Rb and
p53, known to be involved in the negative regulation of
cell proliferation in an effort to understand at a bio-
chemical level the information obtained in genetic anal-
yses. In addition, we will examine the effects ofras on
various cell-cycle genes. Itis interestingthatras causes
REF52 and other cells to arrest in G2 upon removal of
SV40 large T-antigen (27,37). The control of the cells
cycle in G2 has been described in a variety oforganisms
and can involve a protein kinase identified as: a) a com-
ponent of maturation promoting factor (MPF), b) a 34
kDa protein in mammalian cells, c) a starfish histone M-
phase kinase, and d) products of the CDC2 and cdc28
genes of S. pombe and S. cerevisiae, respectively
(38,39). That ElA both induces p34 in baby rat kidney
cells (40) and binds to a cyclinlike molecule (41) as well
as the observation that ras-expressing REF52 cells ar-
rest in G2 suggests that p34 may influence complemen-
tation between these oncogenes. For example, ElA
may protect against the repression ofp34 expression or
activity by ras.
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